by: ASRM Office of Public Affairs
Published in ASRM Press Release
Note: All information is embargoed until the time of presentation at the meeting, unless otherwise indicated.
HIGHLIGHTS FROM THE 68th ANNUAL MEETING OF THE AMERICAN SOCIETY FOR REPRODUCTIVE MEDICINE
Embargoed for Release: Monday, October 22, 2012 – 5:00 PM Pacific Daylight Time
Contraception Important to Women with Cancer; Women with Breast Cancer Less Likely to Receive Advice
San Diego, CA
– Contraception is important to women receiving treatment for cancer, but women with breast cancer may not receive the same type or degree of counseling given to women with other types of malignancy.
At the 68th Annual Meeting of the American Society for Reproductive Medicine, University of Pennsylvania researchers are presenting a retrospective cohort study in which they found that, while the majority of young female cancer patients believe contraception is very important during treatment, few use effective methods.
One hundred and seven women completed the survey: 56 breast cancer (BC) patients and 51 with other, non-BC malignancies. While 82% of BC patients and 80% of non-BC patients agreed that contraception was very important, only 34% of BC patients and 47% of non-BC patients were using an effective method.
Breast cancer patients were likelier to use an IUD with six of 56 women choosing that method compared to none in the non-BC group. Non-BC patients were much likelier to use contraception containing estrogen and progesterone, with nine of 51 initiating use and 10 of 15 continuing use. No BC patients initiated use of estrogen/progesterone contraception and, in 15 women with BC who had been using it, 14 discontinued use.
The researchers found that women with breast cancer were less likely to receive contraceptive counseling and less likely to desire future fertility. However, women with cancer sought fertility preservation at similar rates without regard to diagnosis.
“Cancer patients know contraception is important, but the demands created by the treatment of their disease may not leave them much attention to direct to it. Creating greater access to reproductive medicine services could help these patients protect this aspect of their health while in treatment for cancer and improve their overall well-being,” noted Linda Giudice, MD, PhD, President-elect of ASRM.
O-18 Contraceptive and Fertility Practices in Women with Breast Cancer Compared to Those with Other Malignancies
Maslow et al
The American Society for Reproductive Medicine, founded in 1944, is an organization of more than 7,000 physicians, researchers, nurses, technicians and other professionals dedicated to advancing knowledge and expertise in reproductive biology. Affiliated societies include the Society for Assisted Reproductive Technology, the Society for Male Reproduction and Urology, the Society for Reproductive Endocrinology and Infertility, the Society of Reproductive Surgeons and the Society of Reproductive Biologists and Technologists.
Tweet links to your stories using #ASRM2012